There are several molecular subtypes of ALDH1, and in particular, the enzymatic activity of the ALDH1A3 subtype has been shown to induce the expression of tissue transglutaminase (tTG), a GTP-binding protein involved in glioma stem cell survival and chemotherapy resistance. The gene discussed is ALDH1A1; the disease is central nervous system cancer.